Current Employees: If you are currently employed at any of the Universities of Wisconsin, log in to Workday to apply through the internal application process.Job Category:Academic StaffEmployment Type:Terminal (Fixed Term)Job Profile:Researcher IJob Summary:The Hryckowian Lab is seeking a highly organized, detail-oriented Researcher I to serve as the central operational node and technical backbone of the laboratory. This role splits time roughly equally between comprehensive laboratory management (~20 hours/week) and direct bench research assistance (~20 hours/week).The Hryckowian Lab’s research focuses on understanding how resident microbial communities (microbiomes) act as a "microbial shield" to protect against pathogenic bacterial infections, and how to...

Clostridioides difficile is an urgent threat to human health. Current treatments for C. difficile infections (CDIs) are antibiotics and microbiome restoration therapy (MRT) for recurrent cases. Howeve...

Browse Postoc and Research Intern vacancies at UW–Madison.

Current Employees: If you are currently employed at any of the Universities of Wisconsin, log in to Workday to apply through the internal application process.Job Category:Academic StaffEmployment Type...

Browse Postoc and Research Intern vacancies at UW–Madison.

Group B Streptococcus (Streptococcus agalactiae, GBS) is a disease-causing gram-positive bacterial species. Found asymptomatically in the adult gastrointestinal (GI) tract and the female reproductive ...

Group B Streptococcus (Streptococcus agalactiae, GBS) is a leading cause of invasive infections in neonates and adults. The adult gastrointestinal (GI) tract represents an understudied site of asympto...

The Centers for Disease Control and Prevention classifies Clostridioides difficile as an urgent threat to the nation’s health, as it causes 450,000 infections, 15,000 deaths, and 1 billion dollars in excess healthcare costs per year in the United States (1, 2). Most C. difficile infections (CDIs) occur in healthcare settings, where CDI is the most common cause of infectious diarrhea (3). Known and suspected risk factors for CDI include antibiotics, proton pump inhibitors, impaired immune function, advanced age, and diet, all of which are associated with dysbiotic gastrointestinal (GI) microbiomes (4–6). Though most CDIs are associated with antibiotic treatment, 22% of individuals with community-acquired CDI have no recent history of antibiotic use. Factors affecting persistent and recurrent CDIs remain poorly defined (7, 8). Despite the morbidity and mortality caused by C. difficile, up to 15% of healthy adults are asymptomatic carriers of toxigenic C. difficile (9), highlighting the gaps in our understanding of C. difficile.